Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
CN Stock MarketDetailed Quotes
Zhejiang Orient Gene Biotech (688298)
- 24.90
- -0.33-1.31%
Market Closed Jan 16 15:00 CST
5.02BMarket Cap-10.47P/E (TTM)
25.43High24.70Low2.24MlotVolume25.35Open25.23Prev Close55.92MTurnover1.11%Turnover RatioLossP/E (Static)201.60MShares36.0052wk High0.79P/B5.02BFloat Cap21.1452wk Low30.28Limit Up201.60MShs Float239.67Historical High20.18Limit Down2.89%Range %21.14Historical Low--Dividend TTM24.92Avg Price1.15MlotAsk--Div Yield TTM1Lot Size967.44KlotBid
Zhejiang Orient Gene Biotech (688298) Cash Flow
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 8.85%686.03M | 22.65%459.2M | 43.65%244.09M | 47.87%849.07M | 58.37%630.25M | 61.98%374.4M | 99.69%169.93M | -94.43%574.19M | -95.61%397.97M | -97.06%231.14M |
| Refunds of taxes and levies | -18.00%33.05M | -9.88%22.17M | -27.95%10.77M | -79.19%49.59M | -73.27%40.3M | -80.74%24.59M | -25.19%14.95M | -25.14%238.23M | -44.94%150.74M | -76.16%127.68M |
| Cash received relating to other operating activities | -26.98%72.72M | -50.46%39.01M | -51.74%21.16M | -9.76%239.29M | -44.54%99.59M | -46.70%78.74M | -66.31%43.84M | 53.68%265.17M | 50.47%179.56M | 118.42%147.75M |
| Cash inflows from operating activities | 2.81%791.8M | 8.92%520.37M | 20.68%276.02M | 5.60%1.14B | 5.75%770.13M | -5.69%477.74M | -2.76%228.72M | -90.02%1.08B | -92.30%728.27M | -94.02%506.56M |
| Goods services cash paid | -26.14%327.92M | -31.15%219.45M | -44.66%105.62M | -60.60%585.68M | -67.68%444M | -62.90%318.73M | -54.51%190.85M | -62.14%1.49B | -63.54%1.37B | -74.41%859.16M |
| Staff behalf paid | -7.81%356.59M | -6.31%247.74M | -10.87%128.6M | -13.83%529.61M | -24.19%386.81M | -34.39%264.43M | -52.11%144.28M | -56.47%614.6M | -60.03%510.21M | -64.07%403.06M |
| All taxes paid | -4.77%34.47M | -9.23%26.03M | -31.78%14.22M | -83.17%36M | -82.55%36.2M | -85.84%28.68M | -79.83%20.85M | -85.04%213.92M | -85.84%207.45M | -74.03%202.51M |
| Cash paid relating to other operating activities | -15.84%227.46M | -24.13%150.43M | -3.23%81.87M | -17.89%334.98M | 5.36%270.28M | -13.37%198.27M | -40.69%84.61M | -60.53%407.99M | -75.45%256.54M | -74.05%228.87M |
| Cash outflows from operating activities | -16.78%946.44M | -20.55%643.64M | -25.03%330.31M | -45.42%1.49B | -51.56%1.14B | -52.17%810.11M | -54.43%440.58M | -65.10%2.72B | -68.92%2.35B | -72.42%1.69B |
| Net cash flows from operating activities | 57.88%-154.63M | 62.91%-123.27M | 74.38%-54.29M | 78.83%-348.33M | 77.33%-367.15M | 72.00%-332.37M | 71.04%-211.86M | -154.93%-1.65B | -185.32%-1.62B | -150.88%-1.19B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 6.13%500.69M | -17.23%263.2M | -69.25%163.73M | 80.33%996.48M | 0.65%471.8M | -10.86%317.97M | 152.34%532.45M | -16.73%552.58M | -43.29%468.76M | -42.88%356.72M |
| Cash received from returns on investments | -96.56%1.67M | -96.88%818.92K | -89.90%668.55K | -30.46%30.26M | -11.82%48.39M | 20.05%26.25M | -39.26%6.62M | 188.63%43.51M | 2,163.94%54.88M | 2,650.98%21.87M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 309.08%313.56K | 1,315.77%300.14K | 161.78%54.45K | 822.61%7.51M | 168.01%76.65K | --21.2K | --20.8K | -68.49%814.44K | -98.36%28.6K | ---- |
| Cash received relating to other investing activities | 32.91%3.78B | 111.32%2.69B | --1.3B | 6,075.41%3.92B | 19,922.33%2.84B | --1.27B | --0 | 316.53%63.4M | --14.2M | ---- |
| Cash inflows from investing activities | 27.30%4.28B | 82.65%2.95B | 172.02%1.47B | 649.57%4.95B | 525.33%3.36B | 326.69%1.62B | 140.45%539.08M | -5.19%660.31M | -35.25%537.86M | -39.46%378.58M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -46.22%269.79M | -45.91%207.59M | -37.40%152.71M | -7.22%924.09M | -6.89%501.66M | -6.40%383.8M | 0.66%243.92M | -5.31%996.05M | 0.42%538.79M | -1.66%410.04M |
| Cash paid to acquire investments | 49.22%334.31M | 209.24%380.37M | -12.09%309.5M | -32.44%318.22M | 42.08%224.03M | 109.20%123M | 833.98%352.07M | -72.93%471.05M | -80.74%157.68M | -90.99%58.8M |
| Net cash paid to acquire subsidiaries and other business units | ---- | --0 | --0 | 308.49%320.76M | 432.71%322.41M | 432.71%322.41M | --43.82M | -57.53%78.52M | -64.60%60.52M | -30.23%60.52M |
| Cash paid relating to other investing activities | 55.37%3.99B | 31.12%2.16B | --1.29B | 229.14%4.06B | 95,754.98%2.57B | 61,345.16%1.65B | ---- | 1,190.23%1.23B | --2.68M | --2.68M |
| Cash outflows from investing activities | 27.05%4.6B | 10.95%2.75B | 174.62%1.76B | 102.29%5.62B | 376.13%3.62B | 365.37%2.48B | 127.68%639.82M | -9.57%2.78B | -50.22%759.68M | -53.99%532.04M |
| Net cash flows from investing activities | -23.71%-313.71M | 123.64%203.4M | -188.52%-290.63M | 68.36%-670.15M | -14.32%-253.58M | -460.78%-860.58M | -77.29%-100.73M | 10.86%-2.12B | 68.10%-221.81M | 71.10%-153.46M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | --0 | --0 | --360K | --360K | --360K | --360K | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --360K | --360K | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 19.02%346M | 46.72%271M | 126.33%239M | -61.04%300.75M | -58.53%290.7M | -63.06%184.7M | -78.88%105.6M | 1,444.00%772M | 1,302.00%701M | --500M |
| Cash received relating to other financing activities | --2.28M | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 19.66%348.28M | 46.44%271M | 125.56%239M | -61.00%301.11M | -58.48%291.06M | -62.99%185.06M | -78.81%105.96M | 1,444.00%772M | 1,302.00%701M | --500M |
| Borrowing repayment | 42.21%500M | 106.09%406M | 188.89%364M | 35.54%431.7M | 30.76%351.6M | 185.97%197M | --126M | --318.5M | --268.89M | --68.89M |
| Dividend interest payment | -48.81%5.6M | -51.62%3.59M | -49.36%2.05M | -95.55%16.63M | -97.20%10.94M | -97.82%7.43M | 126.54%4.04M | -49.68%373.41M | -47.35%390.64M | -54.11%340.3M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | --0 | ---- | ---- | ---- | ---- | ---- | --22.27M | ---- | ---- |
| Cash payments relating to other financing activities | -79.11%63.39M | -96.62%9.77M | -50.61%2.94M | 896.50%304.52M | 4,836.66%303.51M | 5,484.53%289.06M | --5.95M | 391.95%30.56M | -93.40%6.15M | -89.77%5.18M |
| Cash outflows from financing activities | -14.57%568.99M | -15.02%419.37M | 171.34%368.98M | 4.21%752.85M | 0.06%666.05M | 19.10%493.49M | 7,523.33%135.99M | -3.45%722.46M | -20.28%665.68M | -47.70%414.36M |
| Net cash flows from financing activities | 41.14%-220.71M | 51.90%-148.37M | -332.89%-129.98M | -1,011.93%-451.74M | -1,161.60%-374.99M | -460.15%-308.43M | -106.03%-30.03M | 107.09%49.54M | 104.50%35.32M | 110.81%85.64M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -129.43%-2.91M | -95.11%1.65M | -65.06%3.25M | -39.56%51.89M | -89.54%9.89M | -74.49%33.61M | 125.03%9.31M | -84.00%85.85M | -83.31%94.54M | 504.83%131.79M |
| Net increase in cash and cash equivalents | 29.81%-691.96M | 95.46%-66.59M | -41.50%-471.64M | 60.91%-1.42B | 42.40%-985.83M | -30.69%-1.47B | -1.81%-333.31M | -891.06%-3.63B | -273.85%-1.71B | -208.86%-1.12B |
| Add:Begin period cash and cash equivalents | -48.43%1.51B | -48.43%1.51B | -48.43%1.51B | -55.33%2.93B | -55.33%2.93B | -55.33%2.93B | -55.33%2.93B | 7.52%6.56B | 7.52%6.56B | 7.52%6.56B |
| End period cash equivalent | -57.88%818.31M | -1.17%1.44B | -59.98%1.04B | -48.43%1.51B | -59.90%1.94B | -73.11%1.46B | -58.34%2.6B | -55.33%2.93B | -31.59%4.84B | -23.79%5.43B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"